Weekly Dose of Optimism #178
On the one hand, improved technology enables us to collect much more data on patients than ever before, and patients themselves are better able to monitor their own biomarkers. This is good. Even better, artificial intelligence and machine learning are being harnessed to try to digest this massive profusion of data and come up with more definitive
... See morePeter Attia MD • Outlive: The Science and Art of Longevity



Why Neuralink is the most important company this decade!
@neuralink is delivering life-changing value to humanity and is at an inflection point as goes from being a technology in the lab to people’s homes this year.
As an investor, we look for transformative innovations — where technology... See more
